ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 137 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $41,014,000 | +28.2% | 1,291,770 | 0.0% | 0.80% | +26.3% |
| Q3 2014 | $31,984,000 | +9.6% | 1,291,770 | 0.0% | 0.63% | +18.9% |
| Q2 2014 | $29,182,000 | +0.0% | 1,291,770 | +7.7% | 0.53% | +8.3% |
| Q1 2014 | $29,176,000 | +15.7% | 1,199,200 | +18.8% | 0.49% | +15.8% |
| Q4 2013 | $25,220,000 | -46.3% | 1,009,200 | -41.0% | 0.42% | -53.6% |
| Q3 2013 | $46,951,000 | – | 1,709,200 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |